Endocrine symptoms to predict risk of recurrence?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2008
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Antineoplastic Agents, Hormonal (MeSH)
- Arthralgia (MeSH)
- Breast Neoplasms (MeSH)
- Female (MeSH)
- Hot Flashes (MeSH)
- Humans (MeSH)
- Joints (MeSH)
- Medication Adherence (MeSH)
- Neoplasm Recurrence, Local (MeSH)
- Neoplasms, Hormone-Dependent (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Predictive Value of Tests (MeSH)
- Treatment Outcome (MeSH)
- Vasomotor System (MeSH)
published in
- The Lancet Oncology Journal